Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 2
2009 2
2010 1
2011 2
2012 2
2013 3
2014 3
2015 2
2016 2
2018 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Results by year

Filters applied: . Clear all
Page 1
Targeting angiogenesis in bladder cancer.
Elfiky AA, Rosenberg JE. Elfiky AA, et al. Curr Oncol Rep. 2009 May;11(3):244-9. doi: 10.1007/s11912-009-0034-2. Curr Oncol Rep. 2009. PMID: 19336017 Review.
The PI3 kinase signaling pathway in prostate cancer.
Elfiky AA, Jiang Z. Elfiky AA, et al. Curr Cancer Drug Targets. 2013 Feb;13(2):157-64. doi: 10.2174/1568009611313020005. Curr Cancer Drug Targets. 2013. PMID: 23215719 Review.
A phase I study of everolimus and docetaxel in patients with castration-resistant prostate cancer.
Courtney KD, Manola JB, Elfiky AA, Ross R, Oh WK, Yap JT, Van den Abbeele AD, Ryan CW, Beer TM, Loda M, Priolo C, Kantoff P, Taplin ME. Courtney KD, et al. Among authors: elfiky aa. Clin Genitourin Cancer. 2015 Apr;13(2):113-23. doi: 10.1016/j.clgc.2014.08.007. Epub 2014 Oct 22. Clin Genitourin Cancer. 2015. PMID: 25450031 Free PMC article. Clinical Trial.
A novel community-based delivery model to combat cancer disparities.
Waldman LT, Svoboda L, Young BF, Abel GA, Berlin S, Elfiky AA, Freedman RA, Drews M, Holland L, Lathan CS. Waldman LT, et al. Among authors: elfiky aa. Healthc (Amst). 2013 Dec;1(3-4):123-9. doi: 10.1016/j.hjdsi.2013.09.004. Epub 2013 Dec 10. Healthc (Amst). 2013. PMID: 26249781 No abstract available.
Novel agents for advanced bladder cancer.
Sonpavde G, Elfiky AA, Rosenberg JE. Sonpavde G, et al. Among authors: elfiky aa. Ther Adv Med Oncol. 2009 Jul;1(1):37-50. doi: 10.1177/1758834009337776. Ther Adv Med Oncol. 2009. PMID: 21789112 Free PMC article.
Activating mTOR mutations in a patient with an extraordinary response on a phase I trial of everolimus and pazopanib.
Wagle N, Grabiner BC, Van Allen EM, Hodis E, Jacobus S, Supko JG, Stewart M, Choueiri TK, Gandhi L, Cleary JM, Elfiky AA, Taplin ME, Stack EC, Signoretti S, Loda M, Shapiro GI, Sabatini DM, Lander ES, Gabriel SB, Kantoff PW, Garraway LA, Rosenberg JE. Wagle N, et al. Among authors: elfiky aa. Cancer Discov. 2014 May;4(5):546-53. doi: 10.1158/2159-8290.CD-13-0353. Epub 2014 Mar 13. Cancer Discov. 2014. PMID: 24625776 Free PMC article. Clinical Trial.
18 results